Literature DB >> 17195041

[Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas].

W Klapper1, H H Wacker.   

Abstract

Indolent (low-grade) B-cell non-Hodgkin's lymphomas, such as follicular and mantle cell lymphomas, are primarily nodal lymphomas in which lymph node involvement is the dominant clinical feature. The frequency of extranodal manifestations of these primarily nodal lymphomas is often underestimated. The typical growth pattern of nodal lymphomas can be absent or not evaluable because the biopsy specimens are often small in cases with extranodal involvement. Therefore, the immunophenotype of the lymphoma cells is of great importance for the diagnosis of indolent lymphomas with extranodal localizations.

Entities:  

Mesh:

Year:  2007        PMID: 17195041     DOI: 10.1007/s00292-006-0878-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  14 in total

1.  Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.

Authors:  Christiane Pott; Carsten Schrader; Stefan Gesk; Lana Harder; Markus Tiemann; Thorsten Raff; Monika Brüggemann; Matthias Ritgen; Benedikt Gahn; Michael Unterhalt; Martin Dreyling; Wolfgang Hiddemann; Reiner Siebert; Peter Dreger; Michael Kneba
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

2.  Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage.

Authors:  Patrick Adam; Tiemo Katzenberger; Miriam Eifert; M Michaela Ott; Andreas Rosenwald; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

3.  The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia.

Authors:  I Nenova; N Mateva; N Ananoshtev; J Grudeva-Popova
Journal:  Hematology       Date:  2005-02       Impact factor: 2.269

4.  B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation.

Authors:  N L Harris; A K Bhan
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

5.  Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.

Authors:  P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

6.  Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.

Authors:  Markus Tiemann; Carsten Schrader; Wolfram Klapper; Martin H Dreyling; Elias Campo; Andrew Norton; Francoise Berger; Philip Kluin; German Ott; Stephano Pileri; Ennio Pedrinis; Alfred C Feller; Hartmut Merz; Dirk Janssen; Martin L Hansmann; Han Krieken; Peter Möller; Harald Stein; Michael Unterhalt; Wolfgang Hiddemann; Reza Parwaresch
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

7.  Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.

Authors:  Lorraine Tracey; Alberto Pérez-Rosado; Maria Jesús Artiga; Francisca I Camacho; Antonia Rodríguez; Nerea Martínez; Elena Ruiz-Ballesteros; Manuela Mollejo; Beatriz Martinez; Marta Cuadros; Juan F Garcia; Mark Lawler; Miguel A Piris
Journal:  J Pathol       Date:  2005-06       Impact factor: 7.996

8.  Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Authors:  Kai Fu; Dennis D Weisenburger; Timothy C Greiner; Sandeep Dave; George Wright; Andreas Rosenwald; Michael Chiorazzi; Javeed Iqbal; Stefan Gesk; Reiner Siebert; Daphne De Jong; Elaine S Jaffe; Wyndham H Wilson; Jan Delabie; German Ott; Bhavana J Dave; Warren G Sanger; Lynette M Smith; Lisa Rimsza; Rita M Braziel; H Konrad Müller-Hermelink; Elias Campo; Randy D Gascoyne; Louis M Staudt; Wing C Chan
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

9.  Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.

Authors:  C Schrader; P Meusers; G Brittinger; A Teymoortash; J-U Siebmann; D Janssen; R Parwaresch; M Tiemann
Journal:  Leukemia       Date:  2004-07       Impact factor: 11.528

10.  An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.

Authors:  William G Morice; Janice M Hodnefield; Paul J Kurtin; Curtis A Hanson
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

View more
  1 in total

Review 1.  [Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System].

Authors:  W Brück; A Brunn; W Klapper; T Kuhlmann; I Metz; W Paulus; M Deckert
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.